Tuesday, March 31, 2009

HIV/AIDS Update - Tentative approval emtricitabine and tenofovir disoproxil fumarate tablets, 200 mg/300 mg

March 31, 2009--On March 30, FDA granted tentative approval for emtricitabine and tenofovir disoproxil fumarate tablets, 200 mg/300 mg, manufactured by Matrix Laboratories Ltd. of Hyderabad, India,under the expedited review provisions of the President's Emergency Plan for AIDS Relief

The details can be read here.

No comments: